Cited by 125Hormonal and reproductive studiesAdrenal Hormones and DisordersPain Management and Opioid Use

Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial

Open access
Basaria, Shehzad, Travison, Thomas G., Alford, Daniel, Knapp, Philip E., Teeter, Kjersten, Cahalan, Christine, Eder, Richard, Lakshman, Kishore +8 more·2015·Pain

Abstract

Symptomatic androgen deficiency is common in patients taking opioid analgesics, as these drugs potently suppress the hypothalamic-pituitary-gonadal axis. However, the efficacy of testosterone replacement in this setting remains unclear. The objective of this trial was to evaluate the efficacy of testosterone replacement on pain perception and other androgen-dependent outcomes in men with opioid-induced androgen deficiency. We conducted a randomized, double-blind, parallel placebo-controlled trial at an outpatient academic research center. Participants were men aged 18 to 64 years on opioid analgesics for chronic noncancer pain, and total testosterone levels were <350 ng/dL. Participants were randomly assigned to 14 weeks of daily transdermal gel that contained 5 g of testosterone or placebo. Primary outcomes were changes in self-reported clinical pain and objectively assessed pain sensitivity. Sexual function, quality of life, and body composition were also assessed. The mean age was 49 years. The median total and free testosterone levels at baseline were 243 ng/dL and 47 pg/mL and 251 ng/dL and 43 pg/mL in the testosterone and placebo arm, respectively. Of the 84 randomized participants, 65 had follow-up data on efficacy outcomes. Compared with men assigned to the placebo arm, those assigned to testosterone replacement experienced greater improvements in pressure and mechanical hyperalgesia, sexual desire, and role limitation due to emotional problems. Testosterone administration was also associated with an improvement in body composition. There were no between-group differences in changes in self-reported pain. In conclusion, in men with opioid-induced androgen deficiency, testosterone administration improved pain sensitivity, sexual desire, body composition, and aspects of quality of life.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.j.pain.0000460308.86819.aa

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Basaria, S., Travison, T. G., Alford, D., Knapp, P. E., Teeter, K., Cahalan, C., Eder, R., Lakshman, K., Bachman, E., Mensing, G., Martel, M. O., Le, D., Stroh, H., Bhasin, S., Wasan, A. D., & Edwards, R. R.
Affiliations
  • Boston University (US)
  • Brigham and Women's Hospital (US)
  • University of Pittsburgh (US)
Corresponding author
Basaria, Shehzad
Venue
Pain
Published
2015-02
Volume
156
Issue
2
Pages
280-288
ISSN
0304-3959 (ISSN-L)
OpenAlex
W2004488462
Cited by
125
References
41
Citations by year
2026: 5 · 2025: 8 · 2024: 8 · 2023: 10 · 2022: 13 · 2021: 12 · 2020: 12 · 2019: 8 · 2018: 16 · 2017: 7 · 2016: 21 · 2015: 4
FWCI
13.87
Type
journal article
Language
en
Open access
Locations
  • Pain (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5p30ag031679-15)
  • Clinical and Translational Science Institute, Boston University
  • National Institute on Aging (P30-AG031679)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
testosterone replacement therapy, chronic non-cancer pain, transdermal testosterone gel, pain sensitivity, hyperalgesia, sexual desire, quality of life, body composition, men
MeSH terms
Administration, Cutaneous, Adult, Analgesics, Opioid, Androgens, Double-Blind Method, Humans, Male, Middle Aged, Pain, Testosterone, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review